| Advancing health care via artificial intelligence: From concept to clinic GS Ganesh, AS Kolusu, K Prasad, PK Samudrala, KVS Nemmani European Journal of Pharmacology 934, 175320, 2022 | 14 | 2022 |
| Neuroprotective effect of Saroglitazar on scopolamine-induced Alzheimer’s in rats: insights into the underlying mechanisms G Sandeep Ganesh, P Konduri, AS Kolusu, SV Namburi, BTC Chunduru, ... ACS Chemical Neuroscience 14 (18), 3444-3459, 2023 | 4 | 2023 |
| Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF B Yerraguravagari, NP Penchikala, AS Kolusu, GS Ganesh, P Konduri, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2024 | 2 | 2024 |
| Ameliorative effect of ferulic acid on thyroid dysfunction against propyl-thiouracil induced hypothyroid rats S Rongala, AS Kolusu, MS Jakkamsetti, SK Mohanty, PK Samudrala, ... Endocrine, 1-18, 2024 | 1 | 2024 |
| Levosimendan ameliorates the scopolamine induced cognitive impairment via modulating pCREB/BDNF expression, cholinergic neurotransmission and neuroinflammation AS Kolusu, GS Ganesh, M Nagabhairava, RMR Madhana, P Konduri, ... | | 2023 |
Dr. Pavan Kumar SamudralaAssociate Professor, Department of Pharmacology, Shri Vishnu College of Pharmacy在 svcp.edu.in 的电子邮件经过验证
